Warrilow, A., Hull, C. M., Parker, J., Garvey, E. P., Hoekstra, W. J., Moore, W. R., . . . Hull, C. (2014). The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme. Antimicrobial Agents and Chemotherapy, 58(12), pp. 7121-7127. doi:10.1128/AAC.03707-14
Chicago Style CitationWarrilow, Andrew, et al. "The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida Albicans CYP51 but Fails To Bind the Human Enzyme." Antimicrobial Agents and Chemotherapy 58, no. 12 (2014): 7121-7127.
MLA CitationWarrilow, Andrew, et al. "The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida Albicans CYP51 but Fails To Bind the Human Enzyme." Antimicrobial Agents and Chemotherapy 58.12 (2014): 7121-7127.